Summary A brief update from my last coverage (11th July): I gave Cellebrite (NASDAQ:CLBT) a buy rating as the business’s strong competitive advantage, mission-critical
It appears more investors are eyeing dividend stocks ahead of the Federal Reserve’s interest rate decision in September. Paul Baiocchi of SS&C ALPS Advisors
Boeing will return its Starliner capsule from the International Space Station without the NASA astronauts that it delivered to orbit in early June, the